Merus Labs Inc.

Norgine BV ’s acquisition of Canada’s Merus Labs International Inc. , which closed on July 17, 2017, is the largest to date for the privately held European specialty company, and the first involvi

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

The pressure on major specialty companies to reduce costs and rein back on their expansionary business strategies in order to reduce debt may be having a knock-on effect on smaller specialty companies

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc